You are here

Eli Lilly

FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety

Fierce Biotech

Thu, 06/6/24 - 11:45 am

Alzheimer's disease

Top ten biopharma R&D deals of 2024

Nature

Wed, 06/5/24 - 11:24 am

Argo Biopharmaceutical

MOMA Therapeutics

Boehringer Ingelheim

Suzhou Ribo Life Science

Isomorphic Labs

Gilead Sciences

Umoja Biopharma

Caris Life Sciences

Voyager Therapeutics

Lilly’s Tirzepatide Shows Positive Phase II NASH Data, Tees Up Potential Expansion

BioSpace

Wed, 06/5/24 - 11:08 am

clinical trials

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Fierce Pharma

Tue, 06/4/24 - 11:38 am

type 2 diabetes

Eli Lilly adds ALS drug prospect with QurAlis deal

BioPharma Dive

Mon, 06/3/24 - 11:55 am

'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences

Fierce Pharma

Mon, 06/3/24 - 11:54 am

Gilead Sciences

Inflation Reduction Act

Weight loss drugs are so hard to find that this company built a tracker

Axios

Thu, 05/30/24 - 11:09 pm

FDA Approves Selpercatinib for Pediatric Patients With RET-Altered Metastatic Thyroid Cancer, Solid Tumors

Oncology Nursing News

Wed, 05/29/24 - 09:41 pm

Weight-loss drug forecasts jump to $150 billion as supply grows

Reuters

Wed, 05/29/24 - 11:48 am

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

Reuters

Fri, 05/24/24 - 11:12 am

drug manufacturing

Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?

BioPharma Dive

Wed, 05/22/24 - 10:28 pm

Eli Lilly’s mirikizumab shows promise in Phase III Crohn’s disease trial

Clinical Trials Arena

Wed, 05/22/24 - 11:17 am

clinical trials

Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins

CNBC

Tue, 05/21/24 - 07:11 pm

Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal

Fierce Biotech

Tue, 05/21/24 - 11:13 am

radiopharmaceuticals

In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1

Fierce Pharma

Thu, 05/16/24 - 09:51 pm

Lilly keeps on Novo's tail by reporting weekly insulin hits primary endpoint in 2 pivotal trials

Fierce Biotech

Thu, 05/16/24 - 11:27 am

Eli Lilly expands U.S. Olympic team sponsorship ahead of 2024 Paris games

Medical Marketing and Media

Wed, 05/15/24 - 10:55 pm

pharma marketing

As Lilly surges, headwinds against its weight loss drugs are growing

Pharma Voice

Wed, 05/15/24 - 11:18 am

Big Pharma’s most improved drugs: a new generation of blockbusters

Pharma Voice

Tue, 05/14/24 - 11:34 am

Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes

Fierce Biotech

Thu, 05/9/24 - 11:48 am

type 2 diabetes

Pages